IGFBP1 and Insulin resistance: In humans, weight loss, reductions in hepatic fat and hepatic insulin resistance and, consequently, reductions in circulating insulin are associated with increases in IGFBP-1 [35], which we also observed in our study in patients with low IGFBP-1 levels at baseline.